文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 临床医学 > MESOMARKTM-A Potential Test for Malignant
侵权投诉

MESOMARKTM-A Potential Test for Malignant

ClinicalChemistry53:4666–672(2007)

CancerDiagnostics

MESOMARK:APotentialTestforMalignant

PleuralMesothelioma

HeatherL.Beyer,RyanD.Geschwindt,CurtisL.Glover,LyTran,

IngegerdHellstrom,Karl-ErikHellstrom,M.CraigMiller,ThorstenVerch,

W.JeffreyAllard,*HarveyI.Pass,andNiranjanY.Sardesai

TM

Background:Solublemesothelin-relatedpeptides(SMRP)havebeenreportedtobepotentialbiomarkersforma-lignantpleuralmesothelioma(MPM).Wereportanalyt-icalandpreliminaryclinicalstudiesofMESOMARKTM,aquantitativeassayforSMRP.

Methods:TheMESOMARKassayisa2-stepimmu-noenzymaticassayinanELISAformatwitha6-pointcalibrationcurve(0–32nmol/L).Weassessedanalyticalimprecision,analytestability,andanalyticalinterfer-ences.WemeasuredSMRPbythisassayin409appar-entlyhealthyindividuals(referenceintervalstudy),177patientswithnonmalignantconditions,and500cancerpatients,including88withMPM.

Results:Thelimitofdetectionwas0.16nmol/L.At2–19nmol/L,intraassayimprecision(CV)was1.1%–5.3%,andtotalimprecisionwas4.0%–11.0%.Themeandilu-tionrecoveryfor5sampleswas109%(range,99%–113%).Nointerferencewasseenfromaddedbilirubin(200mg/L),hemoglobin(500mg/L),triglycerides(30g/L),chemotherapeuticagents,orothertestedsub-stances.Recombinantmesothelinwasstableinserumuponfreeze/thawat 70°Canduponstorageforatleast7daysat2–8°C.The99thpercentileofthereferencegroupwas1.5nmol/L[95%confidenceinterval(CI),1.2–1.6nmol/L;n 409],andmeanSMRPwassignifi-cantlyhigherinserafrompatientswithMPM(7.5nmol/L;95%CI,2.8–12.1nmol/L;n 88).SMRPwasincreasedin52%and5%ofMPMpatientsandasbestos-exposedindividuals,respectively.Concentrationsinothernonmalignantandmalignantconditionsweresimilartothoseinhealthycontrols.

Conclusions:TheMESOMARKassayisanalyticallyrobustandmaybeusefulforthedetectionandmanage-mentofmesothelioma.

©2007AmericanAssociationforClinicalChemistry

Malignantmesotheliomaisahighlyaggressiveneoplasmwithpoorprognosis.Mesotheliomaaccountedfor 1.5%ofthe171900totallungandbronchusmalignanciesintheUSin2003(1,2),andepidemiologicalstudieshaveestab-lishedexposuretoasbestosfibersastheprimarycause(3–5).Althoughmalignantmesotheliomaremainsarela-tivelyuncommonmalignancyintheUS,itcontinuestobeanimportantcauseofmortalityinnumerousareasworld-wide,e.g.,England,Wales,continentalEurope,andAustralia.

Becausethediseaseisasymptomaticinearlystagesanddefinitivediagnosisisdifficult,detectiontypicallyoccursatalatestage,andrecurrencerates,eveninpatientswithsurgicallyresectedtumors,areveryhigh.Treatmentefficacyisroutinelyassessedbyclinicalsymp-tomsandcostlyradiologicimagingtechniqueswithlim-itedsensitivityandspecificity(6).Thus,therehasbeenanincreasingneedforasimplediagnosticbloodtestforscreeningasbestos-exposedpatientsaswellasformoni-toringresponsetotreatment.

TheMESOMARK assaymeasuressolublemoleculesthatarerelatedtothemesothelin/megakaryocytepoten-tiatingfactor(MPF)1familyofproteinsandrecognizedbythemonoclonalantibodyOV569(7).MesothelinandMPFaresynthesizedtogetherasa69-kDaprecursorfromwhichanN-terminal31-kDafragmentisreleasedasMPF,andmesothelinisthe40-kDaC-terminalmembrane-boundfragment.Immunohistochemicalstudiesrevealed

ResearchandDevelopmentDivision,FujirebioDiagnostics,Inc.,Malvern,PA.

*Addresscorrespondencetothisauthorat:ResearchandDevelopmentDivision,FujirebioDiagnostics,Inc.,201GreatValleyPkwy.,Malvern,PA19355.Fax610-240-3803;e-mailallardj@fdi.com.

ReceivedAugust31,2006;acceptedDecember22,2006.

PreviouslypublishedonlineatDOI:10.1373/clinchem.2006.079327

Nonstandardabbreviations:MPF,megakaryocytepotentiatingfactor;SMRP,solublemesothelin-relatedpeptides;HAMA,humanantimouseanti-body;RF,rheumatoidfactor;AUC,areaunderthecurve;CI,confidenceinterval.

1

666

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email